A body shape index is linked with better all-cause mortality discrimination in humans (Compared with body mass index) (AUC 0.65 vs 0.51; ΔAUC 0.14; p<0.001).
“ROC analysis demonstrated superior distinction of all-cause mortality for ABSI compared with BMI (AUC 0.65 vs 0.51; ΔAUC 0.14; p<0.001)”
HumansCompared with body mass indexMedian follow-up 9.7 yearsn = 820
A body shape index was not clearly linked with cancer mortality in humans (Self-reported history of cancer) (HR 1.12, 95% CI 0.96-1.29 per 1-SD higher ABSI).
“but not cancer mortality (HR 1.12, 95% CI 0.96-1.29).”
HumansSelf-reported history of cancerper 1-SD higher ABSIMedian potential follow-up of 7.9 yearsn = 3,230
A body shape index is associated with mortality in humans (Korean adults; numerical estimate for men in Q10 versus Q5; fully adjusted models) (Positive linear trend in both sexes; men Q10 versus Q5: aHR 1.58, 95% CI 1.41–1.77).
“ABSI and BVI showed consistent positive linear trends with all-cause mortality in both sexes”
HumansKorean adults; numerical estimate for men in Q10 versus Q5; fully adjusted models2009–2019
A body shape index is associated with mortality in humans (Adjusted for age, gender, smoking, hypertension, diabetes, and eGFR) (HR 1.15 per SD, 95% CI 1.01–1.32; p=0.034).
“ABSI z-score was independently associated with all-cause mortality (HR 1.15 per SD, 95% CI 1.01–1.32; p=0.034)”
HumansAdjusted for age, gender, smoking, hypertension, diabetes, and eGFRPer SD increase in ABSI z-scoreMedian follow-up 9.7 yearsn = 820
A body shape index is linked with a higher risk of mortality in humans (HR = 1.22, 95% CI: 1.12-1.34).
“ABSI was significantly positively associated with breast cancer incidence (OR = 1.21, 95% CI: 1.02-1.44) and all-cause mortality (HR = 1.22, 95% CI: 1.12-1.34)”
A body shape index is linked with a higher risk of cardiovascular disease in humans (multivariable-adjusted, comparing very high vs very low risk group) (OR, 3.75; 95% CI, 1.60-8.78).
“individuals in the very high ABSI risk group had higher odds of prevalent CVD (OR, 3.75; 95% CI, 1.60-8.78) than those in the very low-risk group”
Humansmultivariable-adjusted, comparing very high vs very low risk groupn = 11,448
A body shape index is associated with osteoporosis in humans (OR 1.47, 95% CI 1.12–1.96; J-shaped relationship with threshold at 0.082).
“ABSI was negatively associated with BMD and positively associated with OP risk (males: OR = 1.47, 95%CI 1.12–1.96; females: OR = 1.37, 95%CI 1.12–1.69)”
A body shape index is linked with a higher risk of osteoporosis in crude and adjusted models.
“High ABSI was significantly associated with an increased risk of osteoporosis in participants compared with the lowest quartile of ABSI in both crude and adjusted models.”
Age is associated with a body shape index in humans (Brazilian adults).
“A Body Shape Index increased progressively across age groups in both sexes (p <0.001), with a more pronounced increase observed in women after midlife.”
A body shape index is associated with cardiovascular mortality in humans (Self-reported history of cancer) (HR 1.55, 95% CI 1.26-1.90 per 1-SD higher ABSI).
“Higher ABSI was associated with higher all-cause and CVD mortality among U.S. adults with a self-reported history of cancer.”
HumansSelf-reported history of cancerper 1-SD higher ABSIMedian potential follow-up of 7.9 yearsn = 3,230
A body shape index is linked with a higher risk of falls in humans (OR = 1.15, 95% CI: 1.04-1.27, p = 0.009).
“In adjusted models, ABSI was significantly associated with both any fall (odds ratio [OR] = 1.15, 95% confidence interval [CI]: 1.04-1.27; p = 0.009)”
In 5,304 Chinese adults, one score was linked to new cardiovascular disease with a hazard ratio of 1.213 per standard-deviation increase.In 5,304 Chinese adults, one score was linked to new cardiovascular disease with a hazard ratio of 1.213 per standard-deviation increase.